Anti-PD-1 therapies—a new first-line option in advanced melanoma
Crossref DOI link: https://doi.org/10.1038/nrclinonc.2015.170
Published Online: 2015-09-29
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sullivan, Ryan J.
Flaherty, Keith T.
Text and Data Mining valid from 2015-09-29
Article History
First Online: 29 September 2015
Competing interests
: The authors declare no competing financial interests.